CIK 0001635088 · Large accelerated filer
Roivant Sciences Ltd.
Sign in to watch- Ticker
- ROIV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- Bermuda
- Entity type
- operating
- EIN
- 981173944
- Phone
- 441-295-5950
- Business address
- 7TH FLOOR, 50 BROADWAY, LONDON, United Kingdom, SW1H 0DB
- 4 Shares withheld for taxes CFO gave up 1,635 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 958 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 10,945 shares (to pay taxes)
- 4 Open-market sale President & COO sold 100,000 shares at $10.65 ($1,065,000)
- 4 Open-market sale Chief Accounting Officer sold 227,500 shares at $10.43 ($2,372,825)
- 4 Open-market sale President & COO sold 435,425 shares at an average $10.47 ($4,561,041)
- 4 Shares withheld for taxes CFO gave up 1,896 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 180 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 306 shares (to pay taxes)
- 4 Shares withheld for taxes Director gave up 313 shares (to pay taxes)
- 4 Gift 10% owner gave 13,357,857 shares (gift)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 1,057 shares (to pay taxes)
- 4 Planned sale President & COO sold 100,000 shares at $11.28 ($1,128,000)
- 4 Shares withheld for taxes CEO gave up 11,623 shares (to pay taxes)
- 4 Open-market buy Director bought 16,845,010 shares at $20.00 ($336,900,200)
- 4 Shares withheld for taxes CFO gave up 1,896 shares (to pay taxes)
- 4 Open-market sale President & COO sold 354,604 shares at an average $11.68 ($4,141,662)
- 4 Open-market sale Pres&Chief Investment Officer sold 886,237 shares at an average $12.01 ($10,641,739)
- 4 Shares withheld for taxes CFO gave up 2,129 shares (to pay taxes)
Page 9 of 26 · 511 filings